The H-Wave® small muscle fiber stimulator, a nonpharmacologic alternative for the treatment of chronic soft-tissue injury and neuropathic pain: An extended population observational study

Advances in Therapy

Volumn 23, Issue 5, 2006, Pages 739-749

  Blum, Kenneth ^a   Chen, Thomas J H ^b,c   Martinez Pons, Manuel ^d   DiNubile, N A ^e   Waite, Roger L ^f   Schoolfield, John ^g   Blum, Seth H ^h   Mengucci, Julie ^h   Downs, B William ⁱ   Meshkin, Brian ^j  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b CHANG JUNG CHRISTIAN UNIVERSITY   (Taiwan)

^c CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^d CITY UNIVERSITY OF NEW YORK   (United States)

^e HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^f Euro American Nutraceuticals Inc   (United States)

^g UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^h Synaptamine Inc   (United States)

ⁱ Allied Nutraceutical Research   (United States)

^j Salugen Inc   (United States)

more..

Author keywords

H Wave device; Increased functionality; Neuropathic pain; Nonpharmacologic relief of pain; Pain reduction medication

Indexed keywords

ADULT; AGED; ANALGESIA; ARTICLE; CHRONIC DISEASE; DEVICE; DRUG USE; FEMALE; FUNCTIONAL STATUS; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE EXCITATION; NEUROPATHIC PAIN; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; POPULATION RESEARCH; SELF CARE; SOFT TISSUE INJURY; TREATMENT OUTCOME; TREATMENT RESPONSE; ADOLESCENT; CROSS-SECTIONAL STUDY; ELECTROSTIMULATION THERAPY; METHODOLOGY; MIDDLE AGED; PAIN; PATHOPHYSIOLOGY; PERIPHERAL NEUROPATHY;

ADOLESCENT; ADULT; AGED; CROSS-SECTIONAL STUDIES; ELECTRIC STIMULATION THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN; PERIPHERAL NERVOUS SYSTEM DISEASES; SOFT TISSUE INJURIES;

EID: 33845617608     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02850314     Document Type: Article

References (20)

1. Gureje O, Von Korff M, Simon GE, Gater R. Persistent pain and well-being: a World Health Organization study in primary care. JAMA. 1998;280:147-151.
2. ACOEM Occupational Medicine Practice Guidelines, second edition. Beverly Farms, Mass: OEM Press;2004:115.
3. Blum K, Chen TJ, Ross BD. Innate properties of H-Wave device, a small fiber stimulator provides the basis for a paradigm shift of electro-therapeutic treatment of pain with increased functional restoration associated with human neuropathies by affecting tissue circulation. Med Hypotheses. 2005;64:1066-1067.
4. Blum K, Chen TJH, Ross BD. Innate properties of H-wave device, a small fiber stimulator provides the basis for a paradigm shift of electro-therapeutic treatment of pain with increased functional restoration associated with human neuropathies. Townsend Letters. 2005;Jan:101-104.
5. Kumar D, Marshall HJ. Diabetes peripheral neuropathy: amelioration of pain with transcutaneous electrostimulation. Diabetes Care. 1997;20:1702-1705.
6. Kumar D, Alvaro MS, Julka IS, Marshall HJ. Diabetic peripheral neuropathy: effectiveness of electrotherapy and amitriptyline for symptomatic relief. Diabetes Care. 1998;21:1322-1325.
7. Julka IS, Alvaro M, Kumar D. Beneficial effects of electrical stimulation on neuropathic symptoms in diabetes patients. J Foot Ankle Surg. 1998;37:191-194.
8. Tsang BK, Tajkaushi K, Eichhorn JH. Electrical stimulation reduces symptoms of thermal hypersensitivity from injury of sciatic partial ligation in rats. Anesth Analg. 1998;86:S1-S551.
9. Blum K, DiNubile NA, Teklen T, et al. H-Wave, a nonpharmacologic alternative for the treatment of patients with chronic soft tissue inflammation and neuropathic pain: a preliminary statistical outcome study. Adv Ther. 2006;23:446-455.
10. Kanji GK. 100 Statistical Tests. Thousand Oaks, Calif: Sage Publications, Inc.; 1997.
11. Xu K, Lichterman D, Kipsky RH, et al. Association of specific haplotypes of D2 dopamine receptor gene with vulnerability to heroin dependence in distinct populations. Arch Gen Psychiatry. 2004;61:567-606.
12. Blum K, Noble EP, Sheridan PJ, et al. Allelic association of human dopamine D2 receptor gene in alcoholism. JAMA. 1990;263:2055-2060.
13. Davison SN, Jhangri GS, Johnson JA. Cross sectional validity of a modified Edmonton symptom assessment system in dialysis patients. A simple assessment of symptom burden. Kidney Int. 2006;69:1621-1625.
14. Breecher HK. The powerful placebo. JAMA. 1955;159:1602-1606.
15. Deyo RA, Walsh NE, Schoenfield LS, Ramamurthy S. A controlled trial of transcutaneous electrical nerve stimulation (TENS) and exercise for chronic back pain. N Engl J Med. 1990;322:1627-1634.
16. Turner J, Deyo RA, Loesser J, Von Koriff M, Fordyce W. The importance of placebo effects in pain treatment and research. JAMA. 1994;271:1609-1614.
17. Wager TD. Expectations and anxiety as mediators of placebo effects in pain. Pain. 2005;115:225-226.
18. Fregni F, Boggio PS, Lima MC, et al. A sham-controlled, phase II trial of transcranial direct current stimulation for the treatment of central pain in traumatic spinal cord injury. Pain. 2006;122:11-13.
19. Solomon S, Elkind A, Freitag F, et al. Safety and effectiveness of cranial electrotherapy in the treatment of tension headache. Headache. 1989;29:445-450.
20. Long DM, Uematsu S, Kouba RB. Placebo responses to medical device therapy for pain. Stereotact Funct Neurosurg. 1989;53:149-156.